Cleared Special

K133509 - EASY PLUS II BLOOD GLUCOSE MONITORING SYSTEM,EASY PLUS II MULTI BLOOD GLUCOSE MONITORING SYSTEM,SMARTEST PERSONA II BLOO

K133509 is an FDA 510(k) clearance for EASY PLUS II BLOOD GLUCOSE MONITORING S..., manufactured by Biotest Medical Corp.. The device is a Class 2 Chemistry device with product code NBW cleared through the Special 510(k) pathway after a 99-day FDA review.

K133509 · Biotest Medical Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2014
Decision
99d
Days
Class 2
Risk

K133509 is an FDA 510(k) clearance for the EASY PLUS II BLOOD GLUCOSE MONITORING SYSTEM,EASY PLUS II MULTI BLOOD GLUCOSE.... Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Biotest Medical Corp. (Eatontown, US). The FDA issued a Cleared decision on February 21, 2014 after a review of 99 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Biotest Medical Corp. devices

FDA 510(k) Submission Details - K133509

510(k) Number K133509 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 14, 2013
Decision Date February 21, 2014
Days to Decision 99 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d slower than avg
Panel avg: 88d · This submission: 99d
Pathway characteristics
Modification to existing cleared device.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 421
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K133509.
EM40 SELF-MONITORING BLOOD GLUCOSE SYSTEM
K133389 · Eps Bio Technology Corp. · Apr 2014
ELEMENT TM LITE BLOOD GLUCOSE MONITORING SYSTEM
K133045 · Infopia Co, Ltd. · Apr 2014
EMV3.1 PRO BLOOD GLUCOSE SYSTEM AND EMV3.1 SELF MONITORING BLOOD GLUCOSE SYSTEM
K133647 · Eps Bio Technology Corp. · Feb 2014
GLUCOMENTOR BLOOD GLUCOSE MONITORING SYSTEM, GLUCOMENTOR MULTI BLOOD GLUCOSE MONITORING SYSTEM
K123517 · Sd Biosensor · Jan 2014
ACON ON CALL DIABETES MANAGEMENT SOFTWARE
K131469 · ACON Laboratories, Inc. · Jan 2014
FREESTYLE PRECISION PRO BLOOD GLUCOSE AND B-KETONE MONITORING SYSTEM
K132511 · Abbott Diabetes Care, Inc. · Dec 2013